Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,981 | 195,060 | 121,466 | 35,449 | 0 |
| Other current assets | 0 | 0 | 0 | 2,011 | 0 |
| TOTAL | $177,149 | $198,089 | $124,294 | $38,874 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,205 | 1,044 | 1,056 | 980 | N/A |
| Other Non-Current Assets | 13,653 | 14,072 | 14,457 | 14,870 | 0 |
| TOTAL | $14,858 | $15,116 | $15,513 | $15,850 | $N/A |
| Total Assets | $192,007 | $213,205 | $139,807 | $54,724 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 4,147 | 0 |
| Accounts payable and accrued liabilities | 5,765 | 4,297 | 3,794 | 2,655 | 0 |
| Accrued Expenses | 10,442 | 14,722 | 10,840 | 13,620 | 0 |
| TOTAL | $18,877 | $21,630 | $17,239 | $23,035 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,139 | 7,471 | 7,786 | 193,146 | 0 |
| TOTAL | $8,182 | $8,625 | $9,033 | $194,497 | $N/A |
| Total Liabilities | $27,059 | $30,255 | $26,272 | $217,532 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,061 | 32,945 | 26,669 | 26,646 | N/A |
| Common Shares | 3 | 3 | 3 | N/A | 0 |
| Retained earnings | -224,760 | -203,522 | -181,840 | -167,653 | 0 |
| Other shareholders' equity | -13 | 0 | 0 | 0 | 0 |
| TOTAL | $164,948 | $182,950 | $113,535 | $-162,808 | $0 |
| Total Liabilities And Equity | $192,007 | $213,205 | $139,807 | $54,724 | $0 |